LT3240554T
Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
Abstract
This record has no abstract on file.
Term
9.7 yearsto projected expiry
Projected expiry 15 June 2036, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
51 members in 32 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 201510466 | United Kingdom | A | |
| 201510466 | United Kingdom | A | |
| 201520508 | United Kingdom | A | |
| 201520508 | United Kingdom | A | |
| 201606810 | United Kingdom | A | |
| 201606810 | United Kingdom | A | |
| 2016051770 | United Kingdom | W | |
| 2016051770 | United Kingdom | W | |
| GB20150010466 | – | – | – |
| GB20150020508 | – | – | – |
| GB20160006810 | – | – | – |
| WO2016GB51770 | – | – | – |
Members51
| Document | Office | Kind | |
|---|---|---|---|
| GB201510466D0 | United Kingdom | D0 | |
| GB201520508D0 | United Kingdom | D0 | |
| CA2988661A1 | Canada | A1 | |
| WO2016203218A1 | World Intellectual Property Organization (WIPO) | A1 | |
| TW201710495A | Taiwan Province of China | A | |
| AR104989A1 | Argentina | A1 | |
| EP3240554A1 | European Patent Office (EPO) | A1 | |
| MA41059A | Morocco | A | |
| JP2017535511A | Japan | A | |
| AU2016278067A1 | Australia | A1 | |
| US2017360856A1 | United States of America | A1 | |
| IL255757A | Israel | A | |
| IL255757D0 | Israel | D0 | |
| PE20180243A1 | Peru | A1 | |
| KR20180012846A | Republic of Korea | A | |
| MX2017016560A | Mexico | A | |
| CO2017013443A2 | Colombia | A2 | |
| EA201890048A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN108271354A | China | A | |
| HK1244202A1 | Hong Kong, China | A1 | |
| BR112017025005A2 | Brazil | A2 | |
| JP6426265B2 | Japan | B2 | |
| ZA201707772B | South Africa | B | |
| JP2019048823A | Japan | A | |
| US2019151380A1 | United States of America | A1 | |
| US10322151B2 | United States of America | B2 | |
| EP3240554B1 | European Patent Office (EPO) | B1 | |
| DK3240554T3 | Denmark | T3 | |
| PT3240554T | Portugal | T | |
| LT3240554TThis record | Lithuania | T | |
| MA41059B1 | Morocco | B1 | |
| RS59446B1 | Serbia | B1 | |
| SI3240554T1 | Slovenia | T1 | |
| HRP20191949T1 | Croatia | T1 | |
| HUE045754T2 | Hungary | T2 | |
| MD3240554T2 | Republic of Moldova | T2 | |
| SG10201912323VA | Singapore | A | |
| SG10201912324XA | Singapore | A | |
| PL3240554T3 | Poland | T3 | |
| ES2753779T3 | Spain | T3 | |
| EP3636272A1 | European Patent Office (EPO) | A1 | |
| MA51639A | Morocco | A | |
| CY1122344T1 | Cyprus | T1 | |
| TWI759266B | Taiwan Province of China | B | |
| JP2022088637A | Japan | A | |
| TW202223083A | Taiwan Province of China | A | |
| US11389493B2 | United States of America | B2 | |
| CN108271354B | China | B | |
| AU2016278067B2 | Australia | B2 | |
| CN115364122A | China | A | |
| US2023173001A1 | United States of America | A1 |
Numbers
- Publication, DOCDB
- 3240554
- Publication, EPODOC
- LT3240554T
- Application
- 16731640
- Application, DOCDB
- 16731640
- Application, EPODOC
- LT16731640T
Titles2
- English
- BLAUTIA STERCOSIS AND WEXLERAE FOR USE IN TREATING INFLAMMATORY AND AUTOIMMUNE DISEASES
- Lithuanian
- BLAUTIA STERCOSIS IR WEXLERAE, SKIRTOS NAUDOTI UŽDEGIMINIŲ IR AUTOIMUNINIŲ LIGŲ GYDYMUI
Classification
- CPC, 35
- A61K35/74
- A61K35/747
- A61P29/00
- A61P37/02
- A23L33/135
- C12N1/205
- A23V2002/00
- C12R2001/01
- A61K38/00
- A61P1/00
- A61P1/02
- A61P1/04
- A61P11/00
- A61P11/02
- A61P11/06
- A61P11/16
- A61P17/00
- A61P17/02
- A61P17/06
- A61P19/00
- A61P19/02
- A61P25/00
- A61P25/28
- A61P27/02
- A61P27/14
- A61P35/00
- A61P37/00
- A61P37/06
- A61P37/08
- A61P43/00
- A61P9/10
- A61P9/14
- C07K14/54
- C07K16/24
- A61K2035/11
- IPC, 8
- A61K35 74
- A61K35 745
- A61P1 00
- A61P11 06
- A61P19 02
- A61P25 28
- A61P29 00
- C12N1 20